TARGeTED: Tackling Antimicrobial Resistance through Goal-orientated Thinking in the EPS Disciplines
Lead Research Organisation:
University of York
Department Name: Research and Enterprise Office
Abstract
Antimicrobial resistance (AMR) is a serious threat to human and animal health. The problem is multifactorial, spans across many disciplines and involves stakeholders from right across society's spectrum. Our belief is that by engaging researchers from different disciplines, we can ask new questions and develop new solutions to the AMR challenge. Scientists engaged in EPS can bring novel insights and innovative technologies to many aspects of the AMR challenge but there are barriers to their engagement with goal-orientated, inter-disciplinary research. We have identified the conditions that lead to successful inter-disciplinary research outcomes; receptiveness, understanding, communication, resources and networks. We have put together a programme of activities that will create the time and space for researchers from EPS to engage in thinking about the AMR challenge in such a way that they will be able to identify tractable problems that they can solve. To start with we will focus on areas of research excellence currently being conducted at the University of York that have not to date been applied to AMR research, but promise to provide new insights and innovative solutions. These areas are 'Novel tools for understanding and controlling bacterial behaviour' and 'Novel biosensors and diagnostics'. We recognize that a successful 'Bridging the Gap' programme will bring together collaborations between researchers not yet engaged with the AMR agenda and we have incorporated into our activities strategies to reach these people. The outcome will be an exciting community of inter-disciplinary researchers working on the challenges of AMR that are communicating, sparking ideas, writing papers and applying for further funding.
Planned Impact
Three broad categories of beneficiary have been identified on three different timescales: Immediate, Intermediate and Long-term.
Immediate beneficiaries (within 1-2 years) will be academics, and the research and support staff at UoY. The programme of activities we aim to support will help develop a culture of interdisciplinary 'goal-orientated' research, and lower barriers to collaboration.
- Academics will benefit from new opportunities to win external funding, gain new collaborators, enjoy new research challenges and gain new skills.
- Researchers engaging in pump priming projects will gain experience of working on tractable problems and will benefit from multiple interactions within an interdisciplinary environment.
- Support staff will be trained in facilitation and programme delivery to enable them to support programme objectives more effectively.
Intermediate beneficiaries (between 1 and 5 years) will be stakeholders such as industry, external academics, NHS collaborators and the general public.
- Industry, academic and NHS partners will gain from new methods, ideas and opportunities for developing and refining approaches to their AMR-centred research with UoY staff.
- The general public will benefit from an improved understanding of AMR, the challenges it imposes on individuals and society, and the complex and interdisciplinary nature of the solutions.
Long-term beneficiaries (from 3-15 years onwards) are ultimately those suffering from the effects of AMR, but benefitting from improved treatments, faster diagnostic methods and decision-making tools, thus enhancing their quality of life.
- Industry will gain economic benefit from application of new research and technologies into their products.
- Professionals in the healthcare services will benefit from new practices, procedures and/or tools.
- Policy makers, informed by the outcomes of the research, will review the impact of novel tools, knowledge and processes on health and welfare issues spanning health, economics, and societal agendas.
Immediate beneficiaries (within 1-2 years) will be academics, and the research and support staff at UoY. The programme of activities we aim to support will help develop a culture of interdisciplinary 'goal-orientated' research, and lower barriers to collaboration.
- Academics will benefit from new opportunities to win external funding, gain new collaborators, enjoy new research challenges and gain new skills.
- Researchers engaging in pump priming projects will gain experience of working on tractable problems and will benefit from multiple interactions within an interdisciplinary environment.
- Support staff will be trained in facilitation and programme delivery to enable them to support programme objectives more effectively.
Intermediate beneficiaries (between 1 and 5 years) will be stakeholders such as industry, external academics, NHS collaborators and the general public.
- Industry, academic and NHS partners will gain from new methods, ideas and opportunities for developing and refining approaches to their AMR-centred research with UoY staff.
- The general public will benefit from an improved understanding of AMR, the challenges it imposes on individuals and society, and the complex and interdisciplinary nature of the solutions.
Long-term beneficiaries (from 3-15 years onwards) are ultimately those suffering from the effects of AMR, but benefitting from improved treatments, faster diagnostic methods and decision-making tools, thus enhancing their quality of life.
- Industry will gain economic benefit from application of new research and technologies into their products.
- Professionals in the healthcare services will benefit from new practices, procedures and/or tools.
- Policy makers, informed by the outcomes of the research, will review the impact of novel tools, knowledge and processes on health and welfare issues spanning health, economics, and societal agendas.
Publications
Alfiniyah C
(2017)
Pulse Generation in the Quorum Machinery of Pseudomonas aeruginosa.
in Bulletin of mathematical biology
Brabham RL
(2018)
Palladium-unleashed proteins: gentle aldehyde decaging for site-selective protein modification.
in Chemical communications (Cambridge, England)
Flanagan L
(2018)
The Antimicrobial Activity of a Carbon Monoxide Releasing Molecule (EBOR-CORM-1) Is Shaped by Intraspecific Variation within Pseudomonas aeruginosa Populations.
in Frontiers in microbiology
Miller L
(2022)
Antibiotic-functionalized gold nanoparticles for the detection of active ß-lactamases
in Nanoscale Advances
Pitruzzello G
(2019)
Multiparameter antibiotic resistance detection based on hydrodynamic trapping of individual E. coli.
in Lab on a chip
Pitruzzello G.
(2018)
Fast antimicrobial susceptibility test based on hydrodynamic trapping of single bacteria
in 22nd International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2018
Privat-Maldonado A
(2016)
Spatial Dependence of DNA Damage in Bacteria due to Low-Temperature Plasma Application as Assessed at the Single Cell Level.
in Scientific reports
Privat-Maldonado A
(2018)
Nontarget Biomolecules Alter Macromolecular Changes Induced by Bactericidal Low-Temperature Plasma.
in IEEE transactions on radiation and plasma medical sciences
Pushkin DO
(2016)
Bugs on a Slippery Plane : Understanding the Motility of Microbial Pathogens with Mathematical Modelling.
in Advances in experimental medicine and biology
Sanderson T
(2020)
A Salmochelin S4-Inspired Ciprofloxacin Trojan Horse Conjugate
in ACS Infectious Diseases
Title | Anna Dumitriu |
Description | 'Viral Interventions' is a diptych, derived using the antibiotic producing bacterium Streptomyces coelicolor, genetically modified in antibiotic production, with bacteriophages (sterilised), embroidery, silk. |
Type Of Art | Artwork |
Year Produced | 2016 |
Impact | The diptych, Viral interventions, was displayed at York art gallery from Dec 2016 to Jan, 2017. Plans for further exhibitions are also set for 2017 onwards. |
URL | http://www.normalflora.co.uk |
Description | The award has been pivotal in building a new and sustained "AMR Community" within the university, involving academics from all three faculties and multiple departments. There is now a much greater level of interaction in AMR and other research areas between physical scientists and other disciplines, particularly biology. These new internal collaborations have been/are working on a range of projects funded through both priming funds and external awards. Other key outputs include: - Development of new external collaborations, both academic and non-academic, leading to new external funding applications - Nine peer-reviewed publications, with several more in press - Six follow-on funding awards from the EPSRC worth a total of £4.5 million - Follow-on funding from other research councils, charitable and philanthropic funders amounting to over £1 million. This includes an award from AHRC on a highly interdisciplinary AMR project to our Sociology dept indicates the far reaching effects of our BTG 'TARGeTED' project. Although the emphasis of this AHRC project is not Physical Sciences, the networks and contacts and interest in AMR would not have occurred without BTG. Sociologists are now involved in other AMR grants that do have physical scientists involved and are being asked to speak and advise at other Universities. - Helping to leverage a Department of Health award for £2.5 million to explore 'Economic Methods of Evaluation in Health and Social Care Interventions' - £70k follow-on funding from industry (Unilever) - A series of well-attended public engagement activities - Greater awareness of University senior management of York's strengths and expertise in AMR and the potential for future success of the interdisciplinary approach exemplified - Methods for judging priming fund applications through a pitching process have been formalised and have informed protocols at an institutional level - Creation of a half-day training workshop on 'Communicating with Industry' that has been adopted into ongoing University staff training offering and the format used in support of BBSRC Seeding Catalyst and FTMA award |
Exploitation Route | - There is agreement from the York academic community to continue with the AMR network, and with meetings and support to build collaborations and projects - New facilitation and project development methods and interdisciplinary ways of thinking about new projects which were co-developed with Viadynamics and piloted throughout this scheme are being embedded into wider University approaches to developing new research across a range of areas including Waste, Heritage Science, Energy and Industrial Biotechnology. |
Sectors | Environment Healthcare Manufacturing including Industrial Biotechology Pharmaceuticals and Medical Biotechnology |
Description | A range of existing and new clinical and industrial partners have taken an interest in the findings from the various sub-projects including York Teaching Hospital NHS Foundation Trust, Unilever, Trajan Medical, Redx Pharma, Discova and Smith and Nephew. Further details are included below. Successful work around the detection and prevention of biofilms resulted in York being invited to be member of the National Biofilm Innovation Centre. A 'plus' funded project (Professor Thomas Krauss, Physics) has aided the recognition that York's resonant imaging techniques had a unique advantage in the characterisation of bacteria and the biofilms they form. The technique allows the monitoring of changes in bacterial adhesion and bacterial growth as a response to antimicrobial challenge. For individual bacteria, the technique provides a route towards a point-of-care assay with a potential response time of less than 20 mins, which is a highly exciting prospect. In the biofilm context, the technique promises to help in identifying the best antibiotic to penetrate the film thereby ensuring that the infection is thoroughly cleared. This work has already resulted in several new clinical and industrial partnerships. In particular new collaborations have been established and developed with York Teaching Hospital NHS Foundation Trust to inform the treatment of urinary tract infections, which will assist with generating future impact. Further investment into the IP created is being actively sought. A 'plus' funded sub-project (Professor Martin Bees, Mathematics) helped to demonstrate the feasibility of lactam analogues as components of cleaning products, by providing experimental evidence for efficacy and a mechanistic understanding of the process through visualisation and modelling. This work has successfully primed a larger project in collaboration with Unilever UK. The work will achieve impact through guiding the development of anti-biofilm products that make up a component of Unilever's household care product line. A 'plus' funded sub-project (Professor Peter McGlynn, Biology) has led to initial discussions with two companies, Redx and Discuva, with regard to the discovery of new inhibitor fragments and the development of new screening technologies for identifying inhibitors of bacterial replication. A 'plus' funded sub-project (Dr Marjan van der Woude, Hull York Medical School) has led to a collaboration with Translate: Realising medical technologies innovation in the Leeds City Region who are supporting the development of the technology towards a translatable state. A follow-on funded project under the MRC's 'AMR in a Global Context, project development award' stream exploring 'Drivers of Human Exposure to Antibacterial Resistance in the Sri Lankan Environment' has led to multiple new relationships with academics and policy stakeholders in Sri Lanka. Another related follow-on project funded under the AHRC's 'Understanding Real World Interactions' stream exploring 'Pathways, Practices and Architectures: Containing Antimicrobial Resistance in the Cystic Fibrosis Clinic' has generated new academic and clinical partnerships as well as new relationships with charitable funders that could support future work and with architects interested in applying the findings to their practice. Through working with us and developing an interest and expertise in AMR, Innovation Consultancy firm Viadynamics have gone on to work with MRC and EPSRC (through introductions in part by brokered by York). They have since been commissioned to use their 'AMR Systems Solutions Map' (conceived in part during this project and developed in conjunction with York) to visualise and explore the cross-funder AMR project portfolio. |
First Year Of Impact | 2016 |
Sector | Chemicals,Construction,Environment,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology |
Impact Types | Societal |
Description | Centre for Future Health (Wellcome Trust) |
Amount | £30,300 (GBP) |
Organisation | University of York |
Sector | Academic/University |
Country | United Kingdom |
Start | 11/2017 |
End | 07/2018 |
Description | DRIVERS OF HUMAN EXPOSURE TO ANTIBACTERIAL RESISTANCE IN THE SRI LANKAN ENVIRONMENT |
Amount | £80,618 (GBP) |
Funding ID | MR/R014876/1 |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 11/2017 |
End | 06/2018 |
Description | Digital control of microbes for resilient supply chains |
Amount | £291,000 (GBP) |
Organisation | Innovate UK |
Sector | Public |
Country | United Kingdom |
Start | 03/2022 |
End | 03/2024 |
Description | EPSRC GCRF: Sensors for clean water: a participatory approach for technology innovation |
Amount | £1,182,012 (GBP) |
Funding ID | EP/P027571/1 |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 04/2017 |
End | 04/2020 |
Description | EPSRC Healthcare Impact Partnerships |
Amount | £1,100,000 (GBP) |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 05/2017 |
End | 05/2020 |
Description | EPSRC Resonant and shaped photonics for understanding the physical and biomedical world |
Amount | £1,623,997 (GBP) |
Funding ID | EP/P030017/1 |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 07/2017 |
End | 07/2022 |
Description | EPSRC Strategic Award |
Amount | £61,000 (GBP) |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2016 |
End | 09/2019 |
Description | Economic Methods of Evaluation in Health and Social Care Interventions |
Amount | £2,503,625 (GBP) |
Organisation | Department of Health (DH) |
Sector | Public |
Country | United Kingdom |
Start | 01/2019 |
End | 12/2023 |
Description | Feasibility studies to encourage better management and use of biofilms |
Amount | £30,000 (GBP) |
Organisation | Unilever |
Sector | Private |
Country | United Kingdom |
Start | 01/2017 |
End | 05/2017 |
Description | Feasibility studies to encourage better management and use of biofilms. |
Amount | £48,000 (GBP) |
Organisation | Innovate UK |
Sector | Public |
Country | United Kingdom |
Start | 04/2016 |
End | 01/2017 |
Description | How does low-temperature plasma damage the bacterial outer membrane? |
Amount | £74,076 (GBP) |
Funding ID | 2116412 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2018 |
End | 09/2022 |
Description | Immuno Diagnostix (IDX) - An ultrasensitive, low cost photonic biosensor |
Amount | £963,368 (GBP) |
Funding ID | EP/V047434/1 |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 07/2021 |
End | 08/2024 |
Description | James Burgess scholarship |
Amount | £90,000 (GBP) |
Organisation | Burgess Road Surgery |
Sector | Public |
Country | United Kingdom |
Start | 09/2016 |
End | 09/2020 |
Description | Metalens fluorometer to assess drinking water in Nepal |
Amount | £547,856 (GBP) |
Funding ID | EP/T020008/1 |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 03/2020 |
End | 03/2022 |
Description | Modify-catch-release-repeat: Reversible bioconjugations for controlled release of small molecules from antibodies and their fragments |
Amount | £397,840 (GBP) |
Funding ID | EP/S013741/1 |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 01/2019 |
End | 12/2023 |
Description | PALM/STORM/SIM Super Resolution Microscopy at York |
Amount | £406,499 (GBP) |
Funding ID | BB/T017589/1 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 06/2020 |
End | 06/2021 |
Description | Pathways, Practices and Architectures: Containing Antimicrobial Resistance in the Cystic Fibrosis Clinic (PARC) |
Amount | £200,019 (GBP) |
Funding ID | AH/R002037/1 |
Organisation | Arts & Humanities Research Council (AHRC) |
Sector | Public |
Country | United Kingdom |
Start | 01/2018 |
End | 01/2020 |
Description | Photonic hyperspectral no-label spotter (Phenospot) |
Amount | £954,557 (GBP) |
Funding ID | 221349/Z/20/Z |
Organisation | Wellcome Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 09/2020 |
End | 09/2024 |
Description | Preventing protein-mediated staphylococcal biofilms on medical devices: structural characterization of three extracellular targets |
Amount | £285,231 (GBP) |
Funding ID | PG/17/19/32862 |
Organisation | British Heart Foundation (BHF) |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 11/2017 |
End | 05/2022 |
Description | Research Stage Abroad Fellowship |
Amount | £2,400 (GBP) |
Organisation | São Paulo Research Foundation (FAPESP) |
Sector | Public |
Country | Brazil |
Start | 03/2017 |
End | 07/2017 |
Description | Tandem organocatalysis for the bi-functional modification of proteins |
Amount | £100,609 (GBP) |
Funding ID | EP/P030653/1 |
Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
Sector | Public |
Country | United Kingdom |
Start | 11/2017 |
End | 10/2018 |
Description | The management and use of biofilms, Innovate UK/BBSRC |
Amount | £140,000 (GBP) |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 03/2016 |
End | 10/2016 |
Description | Wellcome Trust CIDACTS studentships |
Amount | £60,000 (GBP) |
Organisation | Wellcome Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 09/2016 |
End | 09/2019 |
Description | Whterose BBSRC DTP Studentship |
Amount | £97,344 (GBP) |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2019 |
End | 09/2023 |
Description | York, Combating Infectious Disease: Computational Approaches in Translational Science (CIDCATS). |
Amount | £150,401 (GBP) |
Funding ID | 109316/Z/15/Z |
Organisation | Wellcome Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 09/2015 |
End | 09/2019 |
Description | National Biofilm Innovation Centre |
Organisation | National Biofilms Innovation Centre |
Sector | Private |
PI Contribution | Invited to join based on York activities in detection and prevention of biofilms which directly links to AMR |
Collaborator Contribution | Invited to join based on York activities in detection and prevention of biofilms which directly links to AMR |
Impact | Nothing as yet |
Start Year | 2019 |
Description | Partnership with Unilever Plc in relation to 'The biophysics of novel anti-biofilm treatments' |
Organisation | Unilever |
Country | United Kingdom |
Sector | Private |
PI Contribution | Our work helped to demonstrate the feasibility of lactam analogues as components of cleaning products, by providing experimental evidence for efficacy and a mechanistic understanding of the process through visualisation and modelling. The work will achieve impact through guiding the development of anti-biofilm products that make up a component of Unilever's household care product line. |
Collaborator Contribution | Worked collaboratively with our research team on the above mentioned work, and also enabled the York team to broaden their network of contacts in other reserach institutions to position us well for forthcoming biofilm-related funding calls. |
Impact | This collaboration led directly to a successful application to Innovate UK, led by Unilever Plc, which has a total value to the University of York of £78,000 |
Start Year | 2015 |
Title | A CHIRPED DIFFRACTIVE ELEMENT, A SENSOR APPARATUS AND A METHOD OF DETECTING AN OPTICAL PROPERTY OF A SAMPLE USING THE CHIRPED DIFFRACTIVE ELEMENT |
Description | Using a resonant photonic grating structure for the detection of protein biomarkers, e.g. markers for infection. The invention allows us to build an instrument, only using low-cost components, that can compete, or even outperform, the laboratory gold standard (ELISA). |
IP Reference | EP3472593 |
Protection | Patent granted |
Year Protection Granted | 2019 |
Licensed | Commercial In Confidence |
Impact | Other patent granted (with minor variations) in US: US10753868 |
Title | BIOCONJUGATION OF POLYPEPTIDES |
Description | Certain embodiments of the present invention relate to methods of forming and manipulating bioconjugates. Particularly, but not exclusively certain embodiments relate to methods of reversible carbon-carbon bond bioconjugation using aldol based chemical reactions at physiological conditions. |
IP Reference | WO2019063958 |
Protection | Patent granted |
Year Protection Granted | 2019 |
Licensed | No |
Impact | None yet |
Description | Delivery the Leeds Darwin Day lecture to the British Humanist Association |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | British Humanist society invited me to deliver a lecture entitled 'Back to the Dark Ages; Evolution and antibiotic resistance'. This was a 1 hour lecture followed by 30 minutes of Q&A. |
Year(s) Of Engagement Activity | 2017 |
URL | https://humanism.org.uk/2017/02/09/is-humanity-heading-back-to-the-dark-ages-professor-maggie-smith-... |
Description | Half-day training workshop on 'Communicating with Industry' |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Other audiences |
Results and Impact | Creation of a half-day training workshop on 'Communicating with Industry' that has been adopted into ongoing University staff training offering and the format utilised in support of BBSRC Seeding Catalyst and FTMA award. |
Year(s) Of Engagement Activity | 2018 |
Description | Pint of Science |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | an evening talking about the micro biome and antibiotics. The evening increased the debate on antibiotic resistance |
Year(s) Of Engagement Activity | 2015 |
URL | https://pintofscience.co.uk/event/resistance-and-virulence/ |
Description | Pint of Science presentation |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Presentation given in York, as part of Pint of Science events, titled 'Following (and looking after) your gut', and based on TARGeTED work, given on 15 May 2018. |
Year(s) Of Engagement Activity | 2018 |
Description | Plasma Conference (Bratislava, Slovakia) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Study participants or study members |
Results and Impact | International conference on plasma medicine: Dr Deborah O'Connell was invited to give a talk at this international conference on the COST microplasma reference source, which was used by members of our research team in work correlating the distribution of key reactive plasma generated species. This served to disseminate our research to a wider academic audience and generated both questions and contacts within the field. |
Year(s) Of Engagement Activity | 2016 |
Description | Presentation at Physics in Food Conference |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Study participants or study members |
Results and Impact | The talk analysed: Guided Mode Resonance Imaging- Monitoring Early Stage Biofilm Formation Presented by: Yue (Christina) Wang, GT Triggs, Chris Reardon and Thomas F Krauss |
Year(s) Of Engagement Activity | 2017 |
Description | TARGeTED 1st workshop |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | We published a video of our first workshop that aimed to bring together researchers interested in AMR from different disciplines. |
Year(s) Of Engagement Activity | 2014 |
URL | https://www.york.ac.uk/staff/research/research-development/targeted-amr-project/launch-event/ |
Description | Yornight |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | And evening of talks on the value of antibiotics, the micro biome and antibiotic resistance. Sparked discussion |
Year(s) Of Engagement Activity | 2015 |
URL | http://yornight.com/2015/activities/medical-society/ |
Description | sky news |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Sky news filmed the research lab and interviews on the subject of AMR |
Year(s) Of Engagement Activity | 2015 |
URL | http://www.gettyimages.co.uk/detail/video/shows-interior-shots-research-scientists-working-in-a-lab-... |